<DOC>
	<DOCNO>NCT02712359</DOCNO>
	<brief_summary>The purpose study evaluate persistence hepatitis A antibody , approximately 8 year 10 year post vaccination complete series Havrix ( 2 dos ) partial series completion ( 1 dose ) .</brief_summary>
	<brief_title>This Study Will Evaluate Persistence Hepatitis A Antibodies , 8 Years 10 Years Later , Children Who Had Received Havrix Selected Health Centres Panama 2007-2008</brief_title>
	<detailed_description>The study comprise two independent cross-sectional survey ( Year 8 Year 10 ) . The first cross-sectional serosurvey evaluate long term persistence immunity approximately 8 year post vaccine administration second cross-sectional study evaluate long term persistence , approximately 10 year post vaccine administration .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Hepatitis A Antibodies</mesh_term>
	<criteria>Subjects whose parent ( ) / LAR ( ) , opinion investigator , comply requirement protocol . Written inform assent/consent obtain subject subject 's parent ( ) / LAR ( ) subject . Children bear 1st January 2005 31st December 2007 . Available HAV vaccination record . Children receive either 1 two dos Havrix select health centre Panama . Children ≥ 7 year &lt; 9 year last dose Persistence Visit 1 ( Year 8 ) child ≥ 9 year &lt; 11 year last dose Persistence Visit 1 ' ( Year 10 ) . Child care Subjects history vaccination hepatitis A vaccine Havrix . Subjects know past history hepatitis A infection , without vaccination receive last dose Havrix ( 1 dose complete 2 dose schedule ) .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Havrix</keyword>
	<keyword>Cross-sectional seroprevalence survey</keyword>
	<keyword>Panama</keyword>
	<keyword>Long-term persistence</keyword>
	<keyword>Hepatitis</keyword>
</DOC>